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Abstract
Etlingera pavieana (Pierre ex Gagnep) R.M.Sm. (Zingiberaceae family) 
is commonly found in Southeast Asia. The rhizome of the plant is used as a 
spice and folk medicine in southeastern Thailand and Cambodia. The extracts, 
essential oil, and compounds from E. pavieana were found to possess a variety of 
pharmacological activities like anti-inflammatory, antioxidant, antiatherogenic, 
and antimicrobial effects. Furthermore, phytochemical studies have reported 
the presence of various chemical constituents, the main being phenylpropanoids 
such as trans-4-methoxycinnamaldehyde (MCD) and 4-methoxycinnamyl 
p-coumarate (MCC). Therefore, E. pavieana seems to be a potential source 
of natural products for treatment of various diseases and promotion of good 
health.
Keywords: Etlingera pavieana, pharmacological activity, phytochemical constituents, 
Zingiberaceae
1. Introduction
Plant-based nutraceuticals or functional foods have gained attention due to their 
health promotion and safety in comparison to synthetic food ingredients [1, 2]. 
Presently, worldwide researchers have focus on scientific evaluation of medicinal 
plants to detect their pharmacological activities. Zingiberaceae family is distributed 
worldwide and comprises approximately 52 genera and 1587 species [3]. It is about 
300 species belonging to 26 genera found in Thailand [4]. The plants in this family 
are the natural sources for traditional medicine, foods, spice, and other ethnobo-
tanical uses [4]. Etlingera pavieana (Pierre ex Gagnep) R.M.Sm. is a member of the 
Zingiberaceae family and a medicinal plant of southeastern Thailand [5]. Several 
in vitro and in vivo pharmacological experiments and phytochemistry studies of  
E. pavieana have been reported. This chapter has presented comprehensive 
information about morphological characteristics, traditional uses, pharmacology 
activities, and phytochemical constituents of E. pavieana, which provide the data to 
plan future studies.
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2.  Botanical description and uses of Etlingera pavieana (Pierre ex 
Gagnep) R.M.Sm.
E. pavieana is endemic to Southeast Asia including Thailand, Cambodia, Laos, 
and Vietnam. This plant is locally known in Thai as rew-hom/raew hawm [5]. It 
is a perennial rhizomatous herb. The leafy shoots can grow to a height of 1–2.5 m 
(Figure 1A). The leaves are narrowly obovate, green, and glabrous (Figure 1B). 
The rhizomes are long-creeping, slender (0.7–1.5 cm in diameter), and fragrant 
(Figure 1C). Inflorescence arises from the rhizomes and is partially embedded in 
the ground (Figure 1D). To date E. pavieana is found in the natural habitats and cul-
tivated in fruit gardens in southeastern Thailand for commercial purposes as food 
and herbs [5]. The young shoots are eaten as a culinary vegetable, and the rhizomes 
are used as a spice, an ingredient in noodle soup “Moo Lieng,” and as medicines. The 
reported medicinal uses of the rhizomes are relieving fever and flatulence and help-
ing the digestive system and diuresis [5, 6]. In Cambodia, the E. pavieana rhizome 
is boiled in water with Amomum verum Blackw. and sugar to make a drink as a tonic 
and as a medicine for relieving stomach disorder and pharyngitis [5].
3. Phytochemical constituents of E. pavieana
It has been recently reported that the investigation of rhizomes of Etlingera 
pavieana from Thailand resulted in isolation of an uncommon compound which is 
(E)-((E)-3-(4-methoxyphenyl)ally) 3-(4-hydroxyphenyl) acrylate or 4-methoxy-
cinnamyl p-coumarate (MCC) (1) and a series of phenylpropanoids such as 
Figure 1. 
Etlingera pavieana (Pierre ex Gagnep) R.M.Sm. whole plant (A), leaves (B), rhizomes (C), inflorescence (D) 
(Photographed by Srisook, K).
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(E)-3-(4-methoxyphenyl)prop-en-1-amine (2), 3-(4-methoxyphenyl) prop-2-
enal, or trans-4-methoxycinnamaldehyde (MCD) (3), (E)-4-methoxycinnamic 
acid (4), and (E)-1-methoxy-4-(3-methoxyprop-1-enyl) benzene (5) as shown in 
Figure 2 [7]. Moreover, Srisook et al. have reported the isolation of the bioactive 
compound 1 and its two precursors, (2E)-3-(4-methoxyphenyl)prop-2-en-1-ol 
or 4-methoxycinnamyl alcohol (MCA) (6) and (E)-3-(4-hydroxyphenyl)prop-
2-enoic acid or p-coumaric acid (CM) (7), from the rhizome of E. pavieana by 
activity-guided isolation [8]. The other three common phenylpropanoids, (E)-4-
methoxycinnamaldehyde (3), trans-anethole (8), and trans-methyl isoeugenol (9), 
were also extracted from the plant by Srisook and colleagues (unpublished data).
The essential oil investigation of rhizome of E. pavieana resulted in trans-ane-
thole (8) (48.5%) and elemicin (10, 13.8%) as major compounds [9], while Srisook 
et al. have investigated that the hydrodistillation of leaves of E. pavieana yielded 
methyl chavicol (11) as the most predominant product (93%) (unpublished data).
4. Pharmacological activities of E. pavieana
It is reported that E. pavieana possess various pharmacological activities such as 
antioxidant [10, 11]; antimicrobial [7, 12]; anticancer against breast, cervix, liver, 
colon, and small cell lung cancer [7, 13]; and anti-inflammatory effects[8, 14–16]. 
The detailed information is shown below.
4.1 Anti-inflammatory effect
Inflammation is a complex biological response to pathogenic agents and chemi-
cal as well as physical stimuli to get rid of the stimulants [17]. Macrophages are 
inflammatory cells that are considered as the first line of defense against various 
Figure 2. 
Chemical structures of some phytochemicals from rhizomes and leaves of E. pavieana.
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stimuli [18]. Upon contact with injurious stimuli, macrophages are activated and 
produce a large amount of inflammatory mediators and cytokines such as reactive 
oxygen species (ROS), nitric oxide (NO), prostaglandins (PGs), tumor necrosis 
factor-α (TNF-α), interleukin-1 (IL-1), IL-6, and IL-12 [19–24]. It is well-known 
that excess and prolonged secretion of these mediators and cytokines has partici-
pated in the pathogenesis of a variety of inflammatory diseases such as inflamma-
tory bowel diseases [25], osteoarthritis [26], cancer [23], multiple sclerosis [27], 
neurodegenerative diseases like Alzheimer’s disease and Parkinson’s disease [28–
30], atherosclerosis, and cardiovascular diseases [24, 31–33]. Therefore, substances 
inhibiting the secretions of these mediators and cytokines may be used to treat or 
prevent a variety of inflammation-related diseases. Since some Zingiberaceae spe-
cies including Curcuma comosa [34], Amomum tsao-ko [35], Kaempferia parviflora 
[36], Zingiber officinale [37], Alpinia officinarum [38], Alpinia pricei Hayata [39], 
and Alpinia katsumadai Hayata [40] exhibit anti-inflammatory effects in vitro and 
in vivo, Srisook and colleagues, therefore, designed the experiment to determine 
anti-inflammatory activity of E. pavieana using lipopolysaccharide (LPS)- induced 
inflammation in RAW 264.7 murine macrophage cell model. A 95% ethanol extract 
of E. pavieana rhizomes was successively fractionated with hexane and ethyl acetate 
which was evaluated for anti-inflammatory effect on macrophage cells by inhibiting 
the production of inducible nitric oxide synthase (iNOS)-catalyzed NO. The hex-
ane, ethyl acetate, and water fractions of rhizomal ethanol extracts of E. pavieana 
displayed anti-inflammatory effect on macrophage cells. Among them, ethyl acetate 
fraction was the most potent fraction. Furthermore, activity-guided isolation of this 
fraction showed that the bioactive compounds were phenolic compounds including 
4-methoxycinnamyl alcohol (MCA), trans-4-methoxycinnamaldehyde (MCD), 
4-methoxycinnamyl p-coumarate (MCC), and p-coumaric acid (CM) [8].
Mankhong et al. reported that 4-methoxycinnamyl p-coumarate, as the most 
potent compound extracted from E. pavieana rhizomes, exhibited an inhibitory 
effect on the production of cyclooxygenase-2 (COX-2)-catalyzed PGE2, NO, IL-1β, 
and TNF-α on LPS-stimulated RAW 264.7 murine macrophages with IC50 values 
of 14.1 ± 2.3, 32.7 ± 4.7, 3.0 ± 0.5, and 26.8 ± 5.7 μM, respectively. MCC compound 
inhibited gene expression of iNOS, COX-2, IL-1β, and TNF-α in a concentration-
dependent manner through downregulating NF-κB, PI3K/Akt, and AP-1 signaling 
pathways [14, 16]. Furthermore, MCC attenuated LPS-reduced COX-1 expression 
in LPS-stimulated RAW 264.7 macrophages. It suggests that MCC possesses anti-
inflammatory activity with selective inhibitory effect on COX expression [14].
Recently, trans-4-methoxycinnamaldehyde, another compound isolated from 
E. pavieana rhizomes, suppressed the formation of NO and PGE2 as well as the 
expression of their synthesizing enzymes, iNOS and COX-2, on LPS- and Pam3CSK4-
induced RAW 264.7 cells. The IC50 values of NO and PGE2 inhibition were 49.9 ± 4.7 
and 87.6 ± 5.6 μM, respectively. The mechanism underlying anti-inflammatory 
activity of MCD could be inactivation of NF-κB and JNK/c-Jun signaling pathways 
[15]. Moreover, MCD showed a significant anti-inflammatory activity in rat models 
of acute inflammation. It was evident from this study that MCD (3 mg/ear) reduced 
ethyl phenylpropiolate (EPP)-induced ear edema by 51.5% inhibition. The second 
animal model used in this study was carrageenan-induced paw edema. Rats were 
orally administrated with MCD at doses of 75, 150, and 300 mg/kg for 1 h before 
injection with carrageenan. MCD can significantly decrease paw edema in a dose-
dependent manner at 1, 3, and 5 h after carrageenan stimulation. Since edema 
formation induced by EPP and carrageenan is attributed to a release of several inflam-
matory mediators [41, 42], it is implied that the mode of MCD anti-inflammatory 
action in vivo model is mediated in part by suppression of inflammatory mediators.
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We also investigated anti-inflammatory effect of essential oil of E. pavieana 
leaves on LPS-induced RAW 264.7 macrophages. The essential oil of E. pavieana 
leaves at 25–100 μg/mL exhibited a concentration-dependent inhibition effect 
on NO production without significant cytotoxicity (Figure 3A). Incubation of 
cells with essential oil caused reduction of iNOS protein and mRNA expression 
(Figure 3B, C). The compound responsible for anti-inflammatory effect of essen-
tial oil of E. pavieana leaves might be methyl chavicol, a main phytoconstituent of 
this essential oil (unpublished data).
Figure 3. 
The inhibitory effect of essential oil of E. pavieana leaves (EO) on LPS-induced NO production (A) and 
iNOS expression. RAW 264.7 cells were incubated with essential oil of E. pavieana leaves and LPS for 24 h 
for determination of NO production and iNOS protein as well as 9 h for mRNA expression. Supernatant was 
collected for the analysis of NO production by Griess reaction. Cells were lysed and determined for protein 
(B) and mRNA (C) expression by Western blot analysis and real-time RT-PCR, respectively. ###p < 0.001 
compared to unstimulated control cells, *p < 0.05, **p < 0.01, and ***p < 0.001, was significantly different from 
LPS-stimulated cells. AG = cells treated with 50 μM aminoguanidine, an iNOS inhibitor.
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4.2 Antiatherogenic effect
Atherosclerosis is a chronic inflammatory disorder which leads to cardiovas-
cular diseases (CVDs) [43, 44]; it is a major cause of death in the world [24, 45]. 
Endothelial dysfunction is an early step in the development of atherosclerosis. It 
involves with reduced NO bioavailability, low-grade inflammation, and oxida-
tive stress [44, 46–48]. The initiation of atherosclerotic lesion is influenced by the 
expression of cell adhesion molecules including vascular cell adhesion molecule-1 
(VCAM-1) and intercellular adhesion molecule-1 (ICAM-1) on the vascular surface 
of the endothelial cells resulting in recruitment of leukocytes into the vascular tissue 
[49]. Inhibiting the expression of ICAM-1 and VCAM-1 leads to reduction of leu-
kocyte emigration and retardation of the development of atherosclerosis. Thus, the 
substance that inhibits the expression of these cell adhesion molecules may be con-
sidered as anti-atherosclerosis agent that prevents vascular inflammatory disorders.
The rhizomal ethanol extract of E. pavieana was assessed for its anti-vascular 
inflammatory effect in human umbilical vein endothelial cells (EA.hy926 cells). 
Endothelial activation is upregulated by various pro-inflammatory cytokines, 
including TNF-α secreted under inflammatory conditions. The E. pavieana extract 
inhibited TNF-α-induced expression of ICAM-1 and VCAM-1 protein and mRNA 
in a concentration-dependent manner. The inhibitory effect of the rhizome extract 
in endothelial cells is caused from interfering with the activation of NF-κB and 
JNK/c-Jun signaling pathways. Moreover, Akt activation by E. pavieana rhizome 
is associated with negative regulation of inflammation. This anti-vascular inflam-
matory activity was attributed in part due to the presence of the two most active 
phenolic compounds of which were 4-methoxycinnamyl p-coumarate and trans-
4-methoxycinnamaldehyde [50].
It is believed that decrease in endothelium-derived NO, produced by endothelial 
NO synthase (eNOS), results in reduced NO bioavailability [44, 49]. Another study 
was carried out to demonstrate antiatherogenic effect of E. pavieana rhizome. 
EA.hy926 endothelial cells incubated with the ethanol extract of E. pavieana 
rhizome (12.5–200 μg/mL) caused increased NO level in a concentration-dependent 
manner. This induction might be partly mediated by the activation of eNOS enzyme 
via phosphorylation at Ser1177 [11].
4.3 Antioxidant effect
Accumulating evidences suggest that not only inactivation of eNOS enzyme 
but also increased superoxide level leads to the reduction in NO bioavailability [24, 
49]. Superoxide anion is produced by the mitochondrial electron transport chain 
and several enzymes in the endothelial cells. Superoxide anion is then oxidized to 
hydrogen peroxide and other physiological reactive species such as hydroxyl radical 
and hypochlorous acid [44]. Moreover, it reacts with NO to form highly reactive 
peroxynitrite leading to eNOS dysfunction [24, 47]. Chronic inflammation is also 
closely associated with oxidative stress which generated excess ROS [24].
The hexane, ethyl acetate, and water fractions of ethanol extract of E. pavieana 
rhizomes have shown in vitro antioxidant effects, which are evaluated by various 
antioxidant activity assays including 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical 
scavenging, reducing power and ferrous ion chelating activity [10]. E. pavieana 
rhizomal extract has also been assayed, its ROS scavenging activity in EA.hy926 
endothelial cells, using 2,7-dichlorodihydrofluorescein diacetate (H2DCF-DA) 
probe. TNF-α markedly induced ROS formation, while the extract (25–100 μg/mL) 
concentration dependently inhibited ROS level [11]. Thus, the data indicate antioxi-
dant effect of E. pavieana mediated in part by counteract with ROS.
7Pharmacological Activities and Phytochemicals of Etlingera pavieana (Pierre ex Gagnep)...
DOI: http://dx.doi.org/10.5772/intechopen.89277
4.4 Anticancer activity
A number of plant-derived compounds can prevent progression of cancer 
[51, 52] and possess anticancer activity [53]. The ethanol extract from E. pavieana 
rhizomes exhibits cytotoxic effect against several cancer cell lines such as breast 
adenocarcinoma MDA-MB-231, hepatoma HepG2, cervical carcinoma HeLa, and 
C33A. The IC50 values were ranging from 160 to 192 μg/mL, respectively. Trans-
4-methoxycinnamaldehyde, an active compound isolated by cytotoxicity-guided 
isolation from E. pavieana rhizomes, has shown cytotoxic effects against C33A, 
colorectal carcinoma HCT116, MDA-MB-231, and HepG2 with the IC50 values of 
34.3, 38.7, 39.3, and 40.7 μM, respectively [13]. Tachai and Nuntawong [7] reported 
that 4-methoxycinnamyl p-coumarate exhibited inhibitory activity on cell growth 
of human breast cancer (MCF7), human oral cavity cancer (KB), and human small 
cell lung cancer (NCI-H187) with IC50 values of 25.1, 20.2, and 34.8 μM, respectively 
[7]. Essential oil from the rhizomes was found to have cytotoxic effect against NCI-
H187 (IC50: 31.7 μg/mL) [7].
4.5 Antimicrobial activity
Various solvent extracts of E. pavieana (ethanol, acetone, dichloromethane, ethyl 
acetate, petroleum ether, and hexane) were found to be active against Gram-positive 
bacteria (Bacillus cereus, B. subtilis, Staphylococcus aureus, Listeria monocytogenes) and 
Gram-negative bacteria (Escherichia coli, Pseudomonas aeruginosa, Vibrio parahae-
molyticus, and Salmonella typhimurium). Antimicrobial activity of leaves was higher 
than that of stem and rhizome [12]. Tachai and Nuntawong demonstrated that hex-
ane, dichloromethane, and methanol extracts of E. pavieana rhizomes were inactive 
against Mycobacterium tuberculosis, while MCC exhibited its antimicrobial activity 
against M. tuberculosis with minimum inhibitory concentration at 50 μg/mL [7].
5. Conclusion
In this chapter, we have provided the information on botanical aspects, dietary 
and traditional uses, phytochemicals, and pharmacological activities of Etlingera 
pavieana which is distributed in Southeast Asia. The major active compounds are 
phenylpropanoids such as trans-4-methoxycinnamaldehyde, and 4-methoxycin-
namyl p-coumarate. Its rhizomes exhibit anti-inflammatory, antioxidant, antiath-
erogenic, antimicrobial, and anticancer activities. The pharmacological activities 
reported here confirm therapeutic efficacy of E. pavieana rhizomes which might 
be developed into medicines or nutraceuticals for the treatment and prevention 
of various diseases, especially inflammation-related diseases. However, in vivo 
toxicology studies of E. pavieana rhizomes should be performed along with the 
clinical trials.
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